Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1263
mi
from
New Brunswick, NJ
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Rutgers University Clinical Research Center
1263
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1289
mi
from
New York, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
1289
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
898
mi
from
Cleveland, OH
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1223
mi
from
Philadelphia, PA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
572
mi
from
Houston, TX
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Center at Houston
572
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
777
mi
from
Salt Lake City, UT
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
University of Utah
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1410
mi
from
Seattle, WA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Swedish Health Services
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1178
mi
from
Los Angeles, CA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Arthritis Associates of Southern California
1178
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1290
mi
from
New York, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Columbia University
1290
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
973
mi
from
Pittsburgh, PA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1063
mi
from
Charleston, SC
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
942
mi
from
London,
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
St. Joseph Health Care London
942
mi
from
London,
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
611
mi
from
Chicago, IL
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
515
mi
from
Rochester, MN
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1309
mi
from
Albany, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Steffens Scleroderma Center
1309
mi
from
Albany, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1301
mi
from
Great Neck, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Northwell Health
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
809
mi
from
Columbus, OH
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
809
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
1127
mi
from
Washington,
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Georgetown University
1127
mi
from
Washington,
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
372
mi
from
Little Rock, AR
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1139
mi
from
San Diego, CA
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Rady Children's Hospital
1139
mi
from
San Diego, CA
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1358
mi
from
Hartford, CT
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Hospital
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1143
mi
from
Orlando, FL
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Hospital for Children
1143
mi
from
Orlando, FL
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1307
mi
from
Honolulu, HI
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
1307
mi
from
Honolulu, HI
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
733
mi
from
Grand Rapids, MI
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Helen DeVos Children's Hospital
733
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
551
mi
from
Minneapolis, MN
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital & Clinics of Minnesota
551
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
197
mi
from
Kansas City, MO
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospitals and Clinics
197
mi
from
Kansas City, MO
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
958
mi
from
Charlotte, NC
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Levine Children's Hospital
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1147
mi
from
Hershey, PA
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center and Children's Hospital
1147
mi
from
Hershey, PA
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1063
mi
from
Charleston, SC
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
618
mi
from
Nashville, TN
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Monroe Carrell Jr Children's Hospital at Vanderbilt
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Dell Children's Blood and Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
569
mi
from
Houston, TX
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Texas Children's Cancer and Hematology Centers
569
mi
from
Houston, TX
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
780
mi
from
Salt Lake City, UT
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Primary Children's Hospital
780
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
416
mi
from
Saint Louis, MO
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
416
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1383
mi
from
Portland, OR
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Randall Children's Hospital
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
6649
mi
from
Beirut,
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
American University of Beirut Medical Center
6649
mi
from
Beirut,
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
1294
mi
from
Bronx, NY
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Children's Hospital at Montefiore
1294
mi
from
Bronx, NY
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
1283
mi
from
Sacramento, CA
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of California-Davis
1283
mi
from
Sacramento, CA
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
1141
mi
from
Orlando, FL
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Nemours Hospital
1141
mi
from
Orlando, FL
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
609
mi
from
Chicago, IL
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Laurie Children's Hospital Of Chicago
609
mi
from
Chicago, IL
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
414
mi
from
Saint Louis, MO
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Washington University in Saint Louis
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
810
mi
from
Columbus, OH
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Research Institute Center for Gene Therapy at Nationwide Children's Hospital
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
347
mi
from
Dallas, TX
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Texas South Western Medical Center of Dallas
347
mi
from
Dallas, TX
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
853
mi
from
Phoenix, AZ
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
St Joseph's Hospital/Barrow Neurological Institute
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
1330
mi
from
Palo Alto, CA
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical Center
1330
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
1339
mi
from
San Francisco, CA
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
San Francisco General Hospital
1339
mi
from
San Francisco, CA
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
1344
mi
from
New Haven, CT
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
1065
mi
from
Jacksonville, FL
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
University of Florida
1065
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
600
mi
from
Chicago, IL
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
600
mi
from
Chicago, IL
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
608
mi
from
Chicago, IL
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
608
mi
from
Chicago, IL
Click here to add this to my saved trials